Medtronic reports third quarter fiscal 2023 financial results

Delivers top and bottom line ahead of expectations, with strength in cardiovascular and neuroscience portfolios dublin , feb. 21, 2023 /prnewswire/ -- medtronic plc (nyse:mdt) today announced financial results for its third quarter of fiscal year 2023, which ended january 27, 2023. key highlights revenue of $7.7 billion was flat as reported and increased 4.1% organic, ahead of expectations gaap diluted eps of $0.92 decreased 16%; non-gaap diluted eps of $1.30 decreased 4%, ahead of expectations company increases fy23 organic revenue growth and eps outlook "we returned to mid-single digit organic growth as we execute our strategy with urgency.
MDT Ratings Summary
MDT Quant Ranking